ImmunoPrecise Antibodies Cash from Investing (TTM) Insights

ImmunoPrecise Antibodies Ltd (IPA)

1.30 +0.02 (+1.56%) USD | NASDAQ | May 06, 16:00

1.30 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 1997. Upgrade now.

Date	Value
January 31, 2024	-0.6845M
October 31, 2023	-0.8794M
July 31, 2023	-1.558M
April 30, 2023	-1.479M
January 31, 2023	-4.400M
October 31, 2022	-4.766M
July 31, 2022	-3.943M
April 30, 2022	-4.151M
January 31, 2022	-1.483M
October 31, 2021	-1.278M
July 31, 2021	-1.751M
April 30, 2021	-1.877M
January 31, 2021	-1.285M
October 31, 2020	-1.945M
July 31, 2020	-1.527M
April 30, 2020	-1.186M
January 31, 2020	-1.654M
October 31, 2019	-1.559M
July 31, 2019	-1.718M
April 30, 2019	-1.671M
January 31, 2019	-4.013M
October 31, 2018	-3.189M
July 31, 2018	-5.495M
April 30, 2018	-5.621M
January 31, 2018

Date	Value
October 31, 2017
July 31, 2017
April 30, 2017
January 31, 2017
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011	0.0224M
September 30, 2011	4.975M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-4.766M

Minimum

Oct 2022

-0.6845M

Maximum

Jan 2024

-2.059M

Average

-1.559M

Median

Oct 2019

Cash from Investing (TTM) Benchmarks